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PObjective: The study objectives were to (1) assess the efficacy of N,O-carboxymethyl
chitosan on postsurgical adhesion formation after cardiac surgery using a rabbit
cardiac injury model and (2) explore the mechanism of action of N,O-carboxymethyl
chitosan in the prevention of postsurgical adhesions using in vitro experimentation.
Methods: In the rabbit cardiac injury model, cardiac injury was generated by abrading
the anterior surface of the heart with gauze and desiccated with oxygen. The rabbits
were then either treated with N,O-carboxymethyl chitosan gel and solution on the in-
jured surface or not treated. Fourteen days or 3 months after surgery, the severity and
area of adhesion between the heart and sternumwere evaluated. In the in vitro adherence
assay, murine fibroblasts and macrophages were labeled with 3H-thymidine and added
to sterile tissue culture plates that had been precoatedwithN,O-carboxymethyl chitosan
solution, culture medium, or hyaluronic acid. After incubation, the cells adherent to
the coated plates were harvested and the levels of 3H-thymidine were measured.
Results: Animals treated with N,O-carboxymethyl chitosan gel and solution showed
significantly (P, .01) reduced severity and area of adhesion formation. Murine fibro-
blasts and macrophages did not adhere to N,O-carboxymethyl chitosan-coated tissue
culture plates, even in the presence of serum.
Conclusion:TheapplicationofN,O-carboxymethyl chitosangel and solution significantly
reduces the severity of postsurgical adhesion formation after cardiac surgery in the rabbit
model. The inability of fibroblasts to adhere to N,O-carboxymethyl chitosan-coated
surfaces suggests that N,O-carboxymethyl chitosan may act as a biophysical barrier.
P
ostsurgical adhesion formation is a common complication of cardiac surgery.
Adhesion formation is not only troublesome for secondary cardiac surgery,
involving increased risks of heart injury and severe hemorrhage, but also
may obliterate the pericardial space and constrict heart function.1 A product that
can prevent adhesion formation after cardiac surgery would be of great benefit. A
number of approaches to reduce or prevent adhesion formation have been examined
in animal models, and some therapies have reached clinical trials and the marketplace.
A common feature in a number of these interventions has been an attempt to establish
a physical barrier between injured surfaces by the application of films or gels.2-4
A chitosan derivative, N,O-carboxymethyl chitosan (NOCC), has shown signifi-
cant promise as an antiadhesion agent. A number of reports have provided evidence
that this agent limits adhesion formation and adhesion reformation in animal abdom-
inal injury models.5-7 In addition to the preclinical evidence, NOCC was recently
shown to reduce adhesion reformation in stage I/II clinical trials.8 In the animal
models, the highest efficacy was achieved by applying NOCC gel, and subsequently
NOCC solution, between surgically damaged surfaces rather than at sites distant to the
injury.7 This suggests that NOCC functions as a physical barrier, but the mechanism
of action remains unclear.
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Adhesion formation is initiated by blood coagulation, fol-
lowed by fibrin matrix formation and tissue remodeling.9,10
During these processes, fibroblast deposition on the fibrin
matrix and production of matrix proteins, such as fibrin,
fibronectin, and collagen, occur. Fibrin and fibronectin are
major substratum for attracting the fibroblasts that, along
with collagen, form the predominant components of postsur-
gical adhesions.11,12 Therefore, blockingfibroblast deposition
could be an effective strategy to prevent adhesion formation.
In the present study, we first assess the effect of NOCC gel
and solution on adhesion formation after cardiac surgery in
a rabbit model. Second, we examine the mechanism of action
of NOCC in the prevention of postsurgical adhesions in vitro
experimentation. We demonstrate that application of NOCC
products inhibits postsurgical adhesion formation after car-
diac surgery. In vitro experiments demonstrate that NOCC in-
hibits the adhesion of fibroblasts and macrophages to plastic
surfaces, a finding that is consistent with our hypothesis that
NOCCacts as a physical barrier to prevent fibroblast andmac-
rophage deposition and subsequent adhesion formation.
Materials and Methods
Animals
Female New Zealand White rabbits (2.5–3.0 kg) were purchased
from Charles River, maintained in the Dalhousie University Faculty
of Medicine animal care facility, and provided with food and water
ad libitum. All animal experimentation was undertaken in compli-
ance with the guidelines of the Canadian Council of Animal Care.
Cell Lines
Mouse 3T3 fibroblasts and mouse J774 macrophages were pur-
chased from the American Type Culture Collection (Manassas,
Va) and maintained in a 75-cm2 tissue culture flask containing Ros-
well Park Memorial Institute [medium] (RPMI) culture medium
(ICN Biomedicals, Aurora, Ohio) supplemented with 10% fetal
calf serum (FCS), 20 mmol/L HEPES, 100 U/mL penicillin, 100
mg/mL streptomycin, 2 mmol/L L-glutamine, and 50 mM 2-mercap-
toethanol (all from Life Technologies, Burlington, ON). Cells were
maintained at the density of 1 3 105 cells/mL to 1 3 106 cells/mL
andwere fed every 3 days by replacementwith fresh culturemedium.
NOCC Solution and Hyaluronic Acid
Sterile NOCC products, including a cross-linked 1% NOCC gel and
a non-crosslinked 2% NOCC, solution were provided by Kyto-
genics Pharmaceuticals Ltd (Halifax, NS, Canada). Both gel and778 The Journal of Thoracic and Cardiovascular Surgery c Aprsolution were used in a sterile manner in the cardiac injury model.
For in vitro experiments, NOCC solution was diluted 1:20 in se-
rum-free RPMI (sfRPMI) to achieve a final concentration of 0.1%
(w/v). Hyaluronic acid (HA) was obtained from Sigma-Aldrich
(Ontario, Canada) and prepared in sfRPMI to achieve a final concen-
tration of 0.4% (w/v) solution. Both 0.1% NOCC and 0.4% HA
were prepared in a sterile manner.
Cardiac Injury Model
Rabbits were anesthetized with ketamine (50 mg/kg) and xylazine
(5 mg/kg) intramuscular injection for induction, followed by endo-
tracheal intubation and mechanical ventilation, and maintained
with isoflurane (3%). Cardiac activity was monitored with electro-
cardiography throughout the entire surgery. After preparation for
aseptic surgery, a midline incision of skin and muscles was
made by scalpel and electrocautery, respectively. Bleeding was
controlled with electrocautery. The thorax was opened via a me-
dian sternotomy using straight surgical scissors, and then a sternal
retractor was placed to obtain adequate exposure. The anterior
pericardium was opened at approximately 4 to 5 cm in length to
expose the anterior surface of the heart. The anterior surface of
the heart (2 3 1 cm) was abraded for 5 minutes with gauze
(to develop punctuate bleeding) and desiccated twice (30 seconds
each time) with oxygen at a flow rate of 5 L/min. After the injury,
the animals were then either treated with NOCC gel and solution
or not treated with any NOCC products (as control group). When
NOCC gel and solution were applied, 5 mL of NOCC gel was
placed on the injured surface of the heart and 2 mL of solution
was applied around the gel. After treatment, leaving the pericar-
dium open, the sternum was closed with interrupted 2-O Dexon
sutures. The muscle and skin were closed in layers with 3-O
Dexon and staples, respectively. Air was sucked from the chest
via a tube placed just before closure of the sternum. All animals
received analgesic (morphine 2.0 mg/kg intravenously) and antibi-
otics (enrofloxacin [Baytril, Bayer Healthcare, Montville, NJ]
5 mg/kg, by subcutaneous injection) at the time of surgery and
2 additional doses of analgesic (buprenorphine, 0.05 mg/kg by
subcutaneous injection) at 12 and 24 hours postsurgery. Animals
recovered in heated cages, with frequent observation, and received
food and water ad libitum.
At 14 days or 3 months after the surgery, rabbits were sacrificed
by lethal injection of sodium pentobarbital (340 mg/mL) for assess-
ment of poststernal adhesion formation (adhesions between the heart
and the sternum). The anterior chest, including the ribs, sternum, and
heart adherent to the sternum, was removed from rabbits. The poste-
rior pericardium was opened, and the edge of adhesions between the
heart and the sternum was marked with Indian ink. The severity of
adhesions was evaluated by measuring the strength of adhesions.
This was graded on a 5-point scale by pulling the heart from the ster-
num and evaluating how well the tissue could be separated: grade
0 5 no adhesions; grade 1 5 very weak adhesions that are easy to
tear apart by hand; grade 2 5 weak adhesions that can be dissected
with fingers; grade 35moderately strong adhesions that require par-
tial dissection with scissors; grade 45 strong adhesions that require
dissectionwith scissors; grade 55 very strong adhesions that require
dissection with scissors. After removal of the heart from the sternum,
the area of adhesion could be visualized by the Indian ink outline.
These were photographed, and the areas of adhesion indicated by
themarkerswere evaluated by a computerized digital image analysis.il 2008
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PIn all cases animals were randomly assigned to the treatment
group or control group before surgery. The surgeon performing
the operation was blinded to the assignment. All animals were
ear tattooed by animal care personnel immediately before the op-
eration. After the cardiac injury was complete, the NOCC gel and
solution were applied by a technician who was aware of the treat-
ment assignment and tattoo number but not otherwise involved in
the operation. On the day of sacrifice, all animals were randomly
presented for evaluation by the animal care staff. Evaluation of
adhesions was performed by the operating surgeon. The surgical
assistant noted the tattoo number and the evaluation. After all an-
imals were evaluated, adhesion data, including the severity and
area of adhesion, were provided to the treatment technician, who
then matched the tattoo numbers recorded with the treatment ap-
plied and the adhesion data recorded.
Adherence Assays
Cell adherence to coated plastic was assessed using radioactive
labeling techniques. Briefly, 3T3 fibroblasts or J774 macrophages
were removed from the stock culture flask by incubating the cells
with Hank’s balanced salt solution containing 0.25% (w/v) trypsin
and 0.1% (w/v) EDTA (Cellgro, Manassas, Va) at 37C for 3 min-
utes and then by scraping the inner surface of the flask with a rubber
cell scraper. The cell suspension was transferred into a 15-mL tube
and centrifuged at 200g for 5 minutes. Cells were resuspended in
sfRPMI and washed with sfRPMI twice by centrifugation. The cells
were labeled with 3H-thymidine (1 mCi/mL, ICN radiochemicals,
Irving, Calif) in sfRPMI for 4 hours at 37C. After washing with
sfRPMI, the cells were resuspended in 1 of the following 5 groups
of media: (1) sfRPMI; (2) sfRPMI 1 2% FCS; (3) sfRPMI 1 5%
FCS; (4) sfRPMI 1 10% FCS; or (5) 100% normal mouse serum.
Cells were then added to the precoated wells of 96-well tissue cul-
ture plates in 2 sets of triplicate wells (each triplicate set is plated
twice) at a concentration of 2 3 104 cells/well. After 90 minutes
of incubation at 37C to allow cells to adhere to the plates, 1 set
of the triplicate wells was washed with serum-free medium 3 times
to remove nonadherent cells before harvesting. The other set of trip-
licate wells was not washed. Cells from both sets were then har-
vested onto glassfiber filtermats (Skatron) using an automatic cell
harvester (Skatron, Sterling, Va). The 3H-thymidine levels were
determined using a b-counter and were expressed as disintegrations
per minute (dpm). The ratio of radioactivity of the first set of wells
(adherent cells) to the second set of wells (nonadherent and adherent
cells) was used to calculate the percent adhesion. Percent adhesion
was calculated using the following formula: (dpm adherent cells/
dpm total cells) 3 100.
The wells of the plate were precoated with 1 of the 3 media:
(1) sfRPMI; (2) 0.1% NOCC; or (3) 0.4% HA. Precoating was
achieved by placing 100 mL of sfRPMI or 0.1% NOCC or 0.4%
HA in the wells followed by incubation at 37C for 18 hours.
The precoated wells were then washed with sterile phosphate-buff-
ered saline (0.15 mol/L NaCl, 0.05 mol/L Na2PO4 pH 7.4) exten-
sively to remove unbound NOCC or HA. Wells coated with serum
free medium were used as controls only.
Statistics Analysis
The Wilcoxon rank-sum test was used to assess the data obtained
from cardiac injury model because it did not follow a normalThe Journal of Thodistribution. One-way analysis of variance was used to analyze
the data obtained from in vitro experimentation.
Results
Application of NOCC Gel and Solution Significantly
Reduced Adhesion Formation After Cardiac Surgery
All of the rabbits that underwent cardiac surgery survived the
surgery and were maintained until sacrifice. At sacrifice, we
only examined adhesions between the epicardium and the
sternum. At sacrifice no gel or solution could be visualized
in the thoracic cavity, indicating that the NOCC gel and
solution had been completely eliminated by the time of sac-
rifice. Thus, no gel or solution was present to bias the blinded
assessment of severity and size of the adhesions.
Twenty animals (10 NOCC treated and 10 controls)
were sacrificed 14 days postsurgery. At the 14-day time
point, all the animals developed postsurgical adhesions be-
tween the anterior surface of the epicardium and the poste-
rior surface of the sternum. However, the severity of
adhesions in NOCC-treated animals was significantly re-
duced compared with that in control animals. As shown
in Table 1, 9 of 10 animals in the control group, which
did not receive NOCC treatment, had strong adhesions
(grades 4 and 5). These adhesions required sharp dissection
to separate the heart from the sternum. In contrast, in the
NOCC-treated group, only 1 of 10 animals showed strong
adhesions (grade 4) and 1 of 10 showed moderate (grade
3) adhesions. Eight of 10 animals showed only weak and
loose adhesions (grades 1 and 2), and these adhesions
were easily separated with fingers. These data demonstrate













1 4 2.24 8.96 3 4.35 13.5
2 1 3.29 3.29 5 6.06 30.3
3 1 4 4 5 3.83 19.15
4 1 1.97 1.97 5 3.11 15.55
5 2 3.38 6.76 4 2.32 9.28
6 1 0.89 0.89 4 2.36 9.44
7 3 2.73 8.19 4 3.09 12.36
8 1 2.18 2.18 5 1.83 9.15
9 1 2.33 2.33 4 2.5 10.0
10 2 1.67 3.34 4 2.17 8.68
Average: 1.70* 2.47 4.19* 4.30 3.16 13.74
NOCC, N,O-carboxymethyl chitosan. Severity of adhesion graded on a scale
of 1 to 5. Area of adhesions expressed as centimeters squared. Cumulative
adhesion score is established by multiplying the severity of adhesions with
the area of adhesions. *Significantly different (P , .01; Wilcoxon rank-sum
test) from control.racic and Cardiovascular Surgery c Volume 135, Number 4 779
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tion after cardiac surgery.
The area of adhesions between the heart and the sternum
was obtained through computerized image analysis, and the
results are shown in Table 1. These results indicate that
there is no significant reduction of the average of adhesion
area in NOCC-treated animals when compared with non-
treated control animals.
A cumulative adhesion score for each animal, which was
calculated by multiplying the adhesion grade and adhesion
area, was used to evaluate the overall adhesion formation.
These data are presented in Table 1. Statistical analysis
confirmed that the average of the cumulative score of the
NOCC-treated group is significantly (P , .01) lower than
that of the nontreated control group.
A second group of animals (7 NOCC treated and 5 con-
trols) was sacrificed 3 months postsurgery. The data from
these animals are presented in Table 2. In contrast with
the 14-day group in which only the severity was reduced,
there was a highly significant reduction in both severity
and area of adhesions in the NOCC-treated group. The
cumulative score (0.95) for the NOCC-treated group was
significantly (P , .001) lower than for the control group
(9.59).
NOCC Coating Prevents Fibroblasts and
Macrophages from Adhering to Coated Surfaces
The data shown in Figure 1, A demonstrate that when the
culture wells were precoated with medium containing
0.1% NOCC, there was a significant reduction in the per-
centage of fibroblasts that adhered. A similar phenomenon
with macrophages is shown in Figure 1, B. A highly signif-
icant (P , .001) reduction of adherence was seen in
NOCC-coated surfaces in comparison with the control,













1 0 0 0 4 1.50 5.99
2 4 1.19 4.76 4 1.86 7.43
3 0 0 0 4 1.27 5.08
4 0 0 0 5 1.41 7.05
5 1 0.44 0.44 5 4.48 22.39
6 2 0.22 0.44
7 2 0.51 1.02
Average: 1.29* 0.34* 0.95* 4.4 2.10 9.59
NOCC, N,O-carboxymethyl chitosan. Severity of adhesion is graded on
a scale of 1 to 5. Area of adhesions expressed as centimeters squared.
Cumulative adhesion score is established by multiplying the severity of
adhesions with the area of adhesions. *Significantly different (P , .01;
Wilcoxon rank-sum test) from control.780 The Journal of Thoracic and Cardiovascular Surgery c Apnoncoated surfaces when both the 3H-thymidine assay
and the 51Cr assay (data not shown) were used.
NOCC Coating Prevents Fibroblasts from Adhering
to the Coated Surface Even in the Presence of Serum
The data in Figure 2 show that 32.7% 6 0.2% of the fibro-
blasts plated in sfRPMI adhered to the wells that had been
precoated with serum-free medium (the first bar from the
left). As seen in the earlier experiments, cells plated in
sfRPMI did not adhere to the NOCC-coated wells (second
bar of histogram). The addition of FCS to the plating media
Figure 1. Precoating of plates with NOCC inhibits adhesion of 3T3
fibroblasts (A) and J774 macrophages (B) to the coated plates in
the 3H-thymidine–labeled adherence assay. The plates were pre-
coated with sfRPMI or sfRPMI containing 0.1% NOCC. Data are ex-
pressed as mean6 standard deviation of triplicate wells and are
representative of four experiments. sfRPMI, Serum-free Roswell
Park Memorial Institute [medium]; NOCC, N,O-carboxymethyl
chitosan.ril 2008
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PFigure 2. Precoating plates with NOCC blocks fibroblast adhesion regardless of the concentration of serum used in
3H-thymidine–labeled adherence assay. The plates were precoated with sfRPMI or sfRPMI containing 0.1% NOCC.
The adhesion of fibroblasts, suspended in RPMI media containing varying concentration of FCS or suspended in
mouse serum (100% normal mouse serum), to the coated plates was measured by the 3H-thymidine assay. Data
are expressed as mean 6 standard deviation of triplicate wells and are representative of 2 experiments. sfRPMI,
Serum-free Roswell Park Memorial Institute [medium]; FCS, fetal calf serum; NMS, normal mouse serum; NOCC,
N,O-carboxymethyl chitosan.did not significantly (P . .05) increase the adherence of
fibroblasts to the coated wells. Even plating the fibroblasts in
100% homologous normal mouse serum did not significantly
increase adhesion to the NOCC-precoated wells (P . .05).
NOCC Acts as a More Efficient Barrier to Cell
Adherence than Hyaluronic Acid
In the final experiment, we tested 0.4% HA as a coating me-
dium to prevent the adhesion of fibroblasts, in comparison
with 0.1% NOCC solution. The results are shown in Figure 3,
As expected, fibroblast adherence to sfRPMI-coated wells
was enhanced if the 3T3 cells were plated in pure mouse se-
rum. Coating the wells with 0.4% HA significantly (P, .05)
reduced the adherence of cells to the plates. This effect of
HA was lost if the cells were plated in mouse serum. In con-
trast, precoating wells with NOCC completely prevented ad-
herence, and the presence of serum in the plating media did
not ablate this adherent inhibition.
Discussion
In previous experiments we demonstrated that application of
NOCC gel and NOCC solution between surgically injured
surfaces significantly reduces postsurgical adhesion forma-
tion and adhesion reformation in a variety of animal
models.5-7 Because blocking adhesion formation may inhibit
normal wound healing, we examined the effect of NOCC onThe Journal of Thorwound healing using a rat aorta anastomosis model, a rat
large bowel anastomosis model, and a rat abdominal skin
healing model.6 We demonstrated that normal healing
occurred in the presence of NOCC, and that NOCC had no
effect on infection at the wound site.6
In the present study, we assessed the ability of the NOCC
gel and solution to prevent adhesion formation after cardiac
surgery in a rabbit cardiac injury model. This is a preclinical
model with significant predictive value for clinical use. In our
experiments, cardiac activity of rabbits was closely moni-
tored with electrocardiography throughout the entire surgery.
This procedure allowed us to successfully complete the car-
diac surgery without the loss of any animals during cardiac
surgery. We selected day 14 postsurgery to evaluate the ad-
hesion formation, an early stage of postsurgery. It has been
suggested that the injured surfaces are most susceptible to ad-
hesion formation between 16 and 36 hours postsurgery and
that the presence of a physical barrier between injured tissue
surfaces during this critical stage would minimize adhesion
formation.13,14 In addition, we assessed adhesion formation
at a more clinically relevant time point (3 months) to assess
the longer term effects of the NOCC treatment.
The data obtained 14 days and 3 months after the cardiac
surgery indicate that NOCC gel and solution significantly
reduce the severity of retrosternal adhesion formation and
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reduces the adhesion area. These data suggest that NOCC
treatment is effective in reducing retrosternal adhesion
formation after cardiac surgery.
To investigate themechanisms responsible for the effect of
NOCC gel and solution on prevention of adhesion formation,
we designed in vitro experiments. We hypothesized that
NOCC prevents adhesion formation by creating a barrier to
fibroblast and macrophage deposition at the site of injury.
Adhesion formation begins with a fibrin matrix, typically as-
sociated with blood coagulation. This matrix is gradually re-
placed by granular tissue mainly containing fibroblasts and
macrophages. Finally, the adhesion matures into a fibrous
band and tissue remodeling occurs.9,10 During the process
of adhesion formation, deposition of fibroblasts and macro-
phages in the matrix is critical. These cells produce critical
components of the matrix and are involved in cell recruitment
to the development of a fibrous band.11 Because the deposi-
tion of fibroblasts and macrophages is a critical step in adhe-
sion formation, we designed experiments to examine whether
NOCC reduces deposition of fibroblasts and macrophages on
tissue culture surfaces in vitro.
We precoated the tissue culture plastic with 0.1% NOCC,
effectively establishing a barrier between the cells and the ad-
herent surface. The precoating virtually eliminated fibroblast
adherence and reduced macrophage adherence by more than
80%. The fact that the cells do not adhere to NOCC-coated
Figure 3. HA does not prevent adhesion of fibroblasts in the pres-
ence of homologous serum. Mouse fibroblasts were suspended in
either sfRPMI or 100% normal mouse serum before plating on tis-
sue culture plates that were precoated with sfRPMI, 0.4% HA, or
0.1% NOCC. Adherence to the plates was measured by 3H-thymi-
dine adherence assay. Data are expressed as mean 6 standard
deviation of triplicate wells and are representative of 2 experi-
ments. sfRPMI, Serum-free Roswell Park Memorial Institute
[medium]; NMS, normal mouse serum; NOCC, N,O-carboxymethyl
chitosan.782 The Journal of Thoracic and Cardiovascular Surgery c Aprsurfaces strongly suggested a barrier effect for NOCC. There-
fore, it is possible that NOCC functions in vivo to block fibro-
blast and macrophage attachment to the injured surfaces, thus
interrupting fibrin matrix formation. The observed reduction
of severity of adhesion formation without reduction in adhe-
sion area after cardiac surgery in this rabbit model may be due
to the reduced deposition of fibroblasts and macrophages in
the developing lesions. Reduced deposition of fibroblasts
and macrophages in these lesions would result in weaker ad-
hesions. In fact, it is primarily the severity of the adhesion
not the extent of adhesion formation, that is significant for
clinical cardiac surgery. Adhesions easily cleared by a
surgeon’s fingers will generally not affect the outcome of
surgery.
It is not clear how the NOCC solution functions as a phys-
ical barrier to prevent fibroblasts from adhering to the coated
plastic surface. Because NOCC is a negatively charged poly-
saccharide, it is possible that during coating, the NOCC
tightly binds to the positively charged culture plate surface
and then presents to the negatively charged cell membranes
of the fibroblasts an inhospitable environment for adherence
Our earlier experiments (Clive Elson, PhD, unpublished data
2004) showed that NOCC adheres strongly to biologica
membranes and that NOCC would be expected to adhere
tightly to significantly damaged surfaces on application.
It is of significant interest that NOCC solution prevents the
deposition and adherence of fibroblasts onto surfaces even in
the presence of extracellular matrix proteins such as vitronec-
tin (in the serum-supplemented media).12 Fibronectin and
vitronectin are 2 major extracellular matrix proteins abundan
in serum. These proteins effectively facilitate the attachmen
of fibroblasts and macrophages to extracellular matrix by
engagement of cell adhesion molecules on the cell sur-
faces.12,15,16 In this study, homologous serum enhances fi-
broblast adherence to tissue culture wells in vitro, probably
reflecting the binding of fibronectin and vitronectin in the se-
rum to the plate, which then facilitates cell adherence. How-
ever, even in the presence of these important serum proteins
fibroblast adherence is blocked if the wells are precoated with
NOCC. Thus, in vivo, NOCC is probably not displaced from
coated surfaces by these, and other, important serum proteins
This is a highly significant finding because serum proteins are
abundant in the operative field. To be effective, NOCC mus
inhibit fibroblast and macrophage adherence in the presence
of serum components.
In this study, we also examined HA because it is the basis
of a number of products tested to reduce postsurgical adhe-
sions.17-19 HA has also been shown to display significan
efficacy in preventing postsurgical adhesions in anima
models.6,20,21 We found that precoating surfaces with HA
significantly reduced, but did not prevent, fibroblast adher-
ence; however, this effect was eliminated by the presence
of serum. This observation may explain why HA is ineffec-
tive in adhesion reformation20 and adhesion formationil 2008
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serum proteins are present in the injured area.
Taken together, our data demonstrate that NOCC products
significantly reduce postsurgical adhesion formation after
cardiac surgery. The reduced severity of adhesion formation
results in adhesions that can be easily separated by fingers.
This would yield significant benefits for clinical cardiac
surgery if it proves true in clinical trials. In addition,
NOCC effectively prevents fibroblast andmacrophage adher-
ence, even in the presence of homologous serum, suggesting
that NOCC acts as a physical barrier in preventing postsurgi-
cal adhesion formation.
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